Methionine Sulfoxide Reductase in Retinal Function
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
M2006031
Summary
Upon aging, many types of protein damage accumulate, and this accumulation is believed to be a major factor in many age-related diseases. Oxidation of the amino acid methionine is one of the most common. Unlike many other types of protein damage, methionine oxidation can be repaired by a unique enzyme called MSRA. We have found that MSRA is important for protecting retinal cells and that loss of this enzyme in mice causes loss of photoreceptors required for visual function. We have also found that this enzyme is preferentially found in the macula. We hypothesize that MSRA is critical for retinal function and that loss of MSRA activity could contribute to age-related macular degeneration. We propose to determine how deletion of MSRA affects the retina and visual function of mice who lack the enzyme relative to normal mice. These studies are likely to provide important insight into understanding age-related macular degeneration and may provide clues towards developing therapies for this disease.
Grants
Related Grants
Macular Degeneration Research
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Brittany Carr, PhD
Investigating AMD-Like Disease in Animal Models
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Brittany Carr, PhD
Macular Degeneration Research
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Heike Kroeger, PhD
Macular Degeneration Research
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Maximilian Pfau, MD